Role of the C-terminal domain of PCSK9 in degradation of the LDL receptors

Journal of Lipid Research

Volumn 52, Issue 10, 2011, Pages 1787-1794

  Holla, Øystein L ^a   Cameron, Jamie ^a   Tveten, Kristian ^a   Strøm, Thea Bismo ^a   Berge, Knut Erik ^a   Laerdahl, Jon K ^a,b   Leren, Trond P ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Endosomes; Low density lipoprotein; Proprotein convertase subtilisin kexin type 9; Recycling; Sorting

Indexed keywords

CHIMERIC PROTEIN; ENZYME PRECURSOR; HISTIDINE; LOW DENSITY LIPOPROTEIN RECEPTOR; PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9; PROTEIN PCSK9; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHIMERA; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

ALANINE; AMINO ACID SEQUENCE; ENDOSOMES; HEP G2 CELLS; HISTIDINE; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, LDL; SERINE ENDOPEPTIDASES; TUMOR CELLS, CULTURED;

EID: 80053192318     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M018093     Document Type: Article

References (23)

1. Goldstein, J. L., H. H. Hobbs, and M. S. Brown. 2001. Familial hypercholesterolemia. In The Metabolic and Molecular Basis of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, NY. 2863-2914.
2. Mousavi, S. A., K. E. Berge, and T. P. Leren. 2009. The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis. J. Intern. Med. 266:507-519.
3. Seidah, N. G., S. Benjannet, L. Wickham, J. Marcinkiewicz, S. B. Jasmin, S. Stifani, A. Basak, A. Prat, and M. Chrétien. 2003. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc. Natl. Acad. Sci. USA. 100:928-933. (Pubitemid 36183932)
4. Zhang, D. W., T. A. Lagace, R. Garuti, Z. Zhao, M. McDonald, J. D. Horton, J. C. Cohen, and H. H. Hobbs. 2007. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation. J. Biol. Chem. 282:18602-18612. (Pubitemid 47100234)
5. Cunningham, D., D. E. Danley, K. F. Geoghegan, M. C. Griffor, J. L. Hawkins, T. A. Subashi, A. H. Varghese, M. J. Ammirati, J. S. Culp, L. R. Hoth, et al. 2007. Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia. Nat. Struct. Mol. Biol. 14:413-419. (Pubitemid 46685885)
6. Piper, D. E., S. Jackson, Q. Liu, W. G. Romanow, S. Shetterly, S. T. Thibault, B. Shan, and N. P. C. Walker. 2007. The crystal structure of PCSK9: a regulator of plasma LDL-cholesterol. Structure. 15:545-552. (Pubitemid 46702689)
7. Kwon, H. J., T. A. Lagace, M. C. McNutt, J. D. Horton, and J. Deisenhofer. 2008. Molecular basis for LDL receptor recognition by PCSK9. Proc. Natl. Acad. Sci. USA. 105:1820-1825. (Pubitemid 351439423)
8. Cameron, J., Ø. L. Holla, K. E. Berge, M. A. Kulseth, T. Ranheim, T. P. Leren, and J. K. Laerdahl. 2008. Investigations on the evolutionary conservation of PCSK9 reveal a functionally important protrusion. FEBS J. 275:4121-4133.
9. Zhang, D. W., R. Garuti, W. J. Tang, J. C. Cohen, and H. H. Hobbs. 2008. Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 105:13045-13050.
10. Ni, Y. G., S. Di Marco, J. H. Condra, L. B. Peterson, W. Wang, F. Wang, S. Pandit, H. A. Hammond, R. Rosa, R. T. Cummings, et al. 2011. A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo. J. Lipid Res. 52:78-86.
11. Yamamoto, T., C. Lu, and R. O. Ryan. 2011. A two-step binding model of PCSK9 interaction with the low density lipoprotein receptor. J. Biol. Chem. 286:5464-5470.
12. Holla, Ø. L., J. K. Laerdahl, T. B. Strøm, K. Tveten, J. Cameron, K. E. Berge, and T. P. Leren. 2011. Removal of acidic residues of the prodomain increases its activity towards the LDL receptor. Biochem. Biophys. Res. Commun. 406:234-238.
13. Holla, Ø. L., J. Cameron, K. E. Berge, T. Ranheim, and T. P. Leren. 2007. Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly. BMC Cell Biol. 8:9.
14. Sørensen, S., T. Ranheim, K. S. Bakken, T. P. Leren, and M. A. Kulseth. 2006. Retention of mutant low density lipoprotein receptor in endoplasmic reticulum (ER) leads to ER stress. J. Biol. Chem. 281:468-476. (Pubitemid 43671209)
15. Cameron, J., Ø. L. Holla, T. Ranheim, M. A. Kulseth, K. E. Berge, and T. P. Leren. 2006. Effect of mutations in the PCSK9 gene on the cell surface LDL receptors. Hum. Mol. Genet. 15:1551-1558.
16. Holla, Ø. L., T. B. Strøm, J. Cameron, K. E. Berge, and T. P. Leren. 2010. A chimeric LDL receptor containing the cytoplasmic domain of the transferrin receptor is degraded by PCSK9. Mol. Genet. Metab. 99:149-156.
17. Bas, D. C., D. M. Rogers, and J. H. Jensen. 2008. Very fast prediction and rationalization of pKa values for protein-ligand complexes. Proteins. 73:765-783. (Pubitemid 352788657)
18. Maxfield, F. R., and T. E. McGraw. 2004. Endocytic recycling. Nat. Rev. Mol. Cell Biol. 5:121-132. (Pubitemid 38160255)
19. Benjannet, S., Y. G. Saavedra, J. Hamelin, M. C. Asselin, R. Essalmani, A. Pasquato, P. Lemaire, G. Duke, B. Miao, F. Duclos, et al. 2010. Effects of the prosegment and pH on the activity of PCSK9: evidence for additional processing events. J. Biol. Chem. 285:40965-40978.
20. Rudenko, G., L. Henry, K. Henderson, K. Ichtchenko, M. S. Brown, J. L. Goldstein, and J. Deisenhofer. 2002. Structure of the LDL receptor extracellular domain at endosomal pH. Science. 298:2353-2358. (Pubitemid 36014201)
21. Cameron, J., Ø. L. Holla, J. K. Laerdahl, M. A. Kulseth, T. Ranheim, T. Rognes, K. E. Berge, and T. P. Leren. 2008. Characterization of novel mutations in the catalytic domain of the PCSK9 gene. J. Intern. Med. 263:420-431. (Pubitemid 351342682)
22. Delano, W. L. 2010. The PyMOL Molecular Graphics System, Version 1.3. Schrödinger, LLC.
23. Matagne, A., B. Joris, and J. M. Frère. 1991. Anomalous behaviour of a protein during SDS/PAGE corrected by chemical modification of carboxylic groups. Biochem. J. 280:553-556.